Microbot Medical appoints Alon Tamir VP Sales EMEA, targets CE mark by end of 2026

Microbot Medical Inc.

Alon Tamir named Vice President of Sales for Europe, Middle East and Asia (EMEA) to lead international expansion.
Company expects CE mark approval by end of 2026; leveraging FDA clearance received September 2025.
Europe has approximately 2.3 million peripheral endovascular procedures annually, comparable to U.S. market size.
LIBERTY Endovascular Robotic System is in full market release in the U.S. after limited market release.

item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-019775
form_type: 8-K
ticker: MBOT
cik: 0000883975
company_name: Microbot Medical Inc.
filed_at: 2026-04-30T23:59:59+00:00
discovered_at: 2026-05-14T18:02:33.865116+00:00
generated_at: 2026-05-15T01:24:48.357702+00:00
sec_items: ["7.01", "9.01"]
event_type: leadership
sentiment: positive
materiality_score: 0.45
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-019775
json_url: https://secwatch.observer/filing/0001493152-26-019775.json
markdown_url: https://secwatch.observer/filing/0001493152-26-019775.md
text_url: https://secwatch.observer/filing/0001493152-26-019775.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/883975/000149315226019775/0001493152-26-019775-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/883975/000149315226019775/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001493152-26-019775

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.